Interleukin 10-deficient colitis: New similarities to human inflammatory bowel disease

British Journal of Surgery

Volumn 87, Issue 10, 2000, Pages 1346-1351

  Kennedy, R J ^a   Hoper, M ^a   Deodhar, K ^a   Erwin, P J ^a   Kirk, S J ^a   Gardiner, K R ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; COLITIS; CORRELATION FUNCTION; ENDOTOXEMIA; ENTERITIS; HISTOPATHOLOGY; HUMAN; INJURY SCALE; INTESTINE MUCOSA PERMEABILITY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; COLITIS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN-10; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SUPPORT, NON-U.S. GOV'T;

EID: 0033772055     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.2000.01615.x     Document Type: Article

References (42)

1. Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis, and experimental intestinal inflammation
2. Review article: Role of the enteric microflora in the pathogenesis of intestinal inflammation and arthritis
3. Experimental models of inflammatory bowel disease
4. Animal models of inflammatory bowel disease - An overview
5. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
6. Spontaneous, heritable colitis in a new substrain of C3H/HeJ mice
7. The germfree state prevents development of gut and joint inflammatory disease of HLA-B27 transgenic rats
8. Interleukin-10-deficient mice develop chronic enterocolitis
9. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses
10. The effect of elemental diet on intestinal permeability and inflammation in Crohn's disease
11. Detection of endotoxin in IBD
12. Gut macromolecular permeability in pancreatitis correlates with severity of disease in rats
13. Controlled trial comparing prednisolone with an elemental diet plus non-absorbable antibiotics in active Crohn's disease
14. Lactobacillus sp prevents development of enterocolitis in interleukin-10 gene deficient mice
15. Endotoxin-polymyxin complexes in an improved enzyme-linked immunosorbent assay for IgG antibodies in blood donor sera to Gram-negative endotoxin core glycolipids
16. Interleukin-10 gene knock-out mice: A model of chronic inflammation
17. Genetic and spontaneous models of inflammatory bowel disease in rodents: Evidence for abnormalities in mucosal immune regulation
18. Subtherapeutic corticosteroids potentiate the ability of interleukin 10 to prevent chronic inflammation in rats
19. Normal intestinal bacteria in ulcerative colitis
20. Influence of inflammatory bowel disease on intestinal microflora
21. Increased incidence of faecal coliforms with in vitro adhesive and invasive properties in patients with ulcerative colitis
22. Peptococcus magnus: A significant human pathogen
23. The faecal flora of patients with Crohn's disease
24. Changes in intestinal microflora in Crohn's disease
25. The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique
26. Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease
27. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice
28. Intestinal permeability in inflammatory bowel disease
29. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora
30. Absorption of 51 chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease
31. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor
32. Chromium 51-ethylenediaminetetraacetate test: A useful test in the assessment of inflammatory bowel disease
33. Reversibility of increased intestinal permeability to 51 Cr-EDTA in patients with gastrointestinal inflammatory diseases
34. Whole-gut irrigation as anti-endotoxinaemic therapy in inflammatory bowel disease
35. Endotoxaemia in patients with Crohn's disease: A longitudinal study of elastase/alpha 1-proteinase inhibitor and Limulus-amoebocyte-lysate reactivity
36. Significance of systemic endotoxaemia in inflammatory bowel disease
37. Intestinal permeability is increased in burn patients shortly after surgery
38. Selective gut nutrition: Food for thought or empty calories?
39. Elemental diet and IV-TPN-induced bacterial translocation is associated with loss of intestinal mucosal barrier function against bacteria
40. Effect of commercially available chemically defined liquid diets on the intestinal microflora and bacterial translocation from the gut
41. Are intestinal permeability, bacterial translocation and intestinal atrophy during TPN and enteral feeding related?
42. Total parenteral nutrition-induced changes in gut mucosal function: Atrophy alone is not the issue